Headquarters
Sites
inno.N was founded in 1984 as part of CJ CheilJedang's Pharmaceutical Business Division, drawing on three decades of expertise in the pharmaceutical industry. In 1986, the company achieved a significant milestone with the development of the 'Hepaccin-B' hepatitis prevention vaccine using entirely domestic technology. It also gained acclaim for its capacity in mass-producing 'interferon,' a cutting-edge medicinal product at the time, and 7-ACA, a raw material necessitating advanced chemical technology.
Country
City